Brief Overview of hyperlipidemia in primary care
Terminology
Dyslipidemia: increased risk of cardiovascular disease, medications may be useful
Hyperlipidemia: elevated total cholesterol, LDL cholesterol, or triglycerides
When to start screening (the answer will depend on what resource you are reading)
- For high-risk patients, I typically start screening around age 20-30.
- For low-risk patients, I usually wait until age 35-40
- Men are higher risk so screening can begin earlier than for women.
When to start a statin
- H/o stroke or coronary heart disease
- LDL >190
- All diabetic patients starting age 40 with LDL 70-189
- LDL 70-189 plus ASCVD risk >7.5
Note- ASCVD risk calculation is risk of cardiovascular event (stroke or heart attack) in next 10 years. Most EMR systems automatically calculate but there is a good app ASCVD Plus that you can plug in patient info (age, gender, race, BP, lipid numbers, history, etc.) and it will calculate for you.
Choice of medication
- My go to is atorvastatin 10-20mg. F/u 2 months to recheck labs, then increase/adjust therapy as needed.
- If they complain of muscle cramps or side effects they can switch to rosuvastatin 5-10mg.
- If not able to tolerate statins, can try ezetimibe 10 mg daily.
PERLS
Medicare typically will not cover lipid panel as a screening. If they have the dx of hyperlipidemia, that will usually work. Can try diagnosis of physical OR screening lipid Z13.220.
Acknowledgments
Pignone, M., Cannon, C. (2024). Low-density lipoprotein cholesterol-lowering therapy in the primary prevention of cardiovascular disease. http://uptodate.com/ contents/low-density-lipoprotein-cholesterol-lowering-therapy-in-the-primary-prevention-of-cardihttps://www.uptodate.com/contents/low-density-lipoprotein-cholesterol-lowering-therapy-in-the-primary-prevention-of-cardiovascular-disease?search=hyperlipidemia&source=search_result &selectedTitle=1%7E150&usage_type=default&display_rank=1#H937406940ovascular-disease?search=hyperlipidemia&source=search_result&selectedTitle=1 %7E150&usage_type=default&display_rank=1#H937406940
Stay connected with news and updates!
Join the mailing list to receive the latest news and updates. Don't worry, your information will not be shared.
We hate SPAM. We will never sell your information, for any reason.